Summary of Purpose
Title: Optimal Delay Time to Initiate Anticoagulation after Ischemic Stroke in Atrial Fibrillation (START): a pragmatic, adaptive randomized clinical trial. Primary Objective: • To determine the optimal time to initiate anticoagulation with a Non-Vitamin K Oral Anticoagulant (NOAC) after ischemic stroke in patients with non-valvular atrial fibrillation. Secondary Objectives: - To...Read More →
The following dates are available for this trial. Trial information last updated on 20 June 2017.
|14 Jun 2017||12 Jan 2017||1 Jun 2021||1 Aug 2021||1 Jun 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|